Latest Articles

Publication Date
All News Scientific
Multiple Subcutaneous Metastases in Endometrial Cancer Treated With Systemic Chemotherapy: A Case Report and Review of the Literature - Cureus

Multiple Subcutaneous Metastases in Endometrial Cancer Treated With Systemic Chemotherapy: A Case Report and Review of the Literature Cureus

Published: Jan. 5, 2025, 6:05 a.m.
Read Full Article
RHOBH's Camille Grammer, Who Beat Cancer, Feels 'Much Better' After Breast Implant Removal - SurvivorNet

RHOBH's Camille Grammer, Who Beat Cancer, Feels 'Much Better' After Breast Implant Removal SurvivorNet

Published: Jan. 4, 2025, 3:36 p.m.
Read Full Article
Peripheral Blood NLR Predicts LEN/PEM Efficacy in Endometrial Cancer - Physician's Weekly

Peripheral Blood NLR Predicts LEN/PEM Efficacy in Endometrial Cancer Physician's Weekly

Published: Dec. 31, 2024, 12:27 p.m.
Read Full Article
Unveiling DNA Methylation: Early Diagnosis, Risk Assessment, and Therapy for Endometrial Cancer - Frontiers

Unveiling DNA Methylation: Early Diagnosis, Risk Assessment, and Therapy for Endometrial Cancer Frontiers

Published: Dec. 30, 2024, 11:50 p.m.
Read Full Article
A novel prognostic score of recurrence for endometrial cancer patients with staging surgery - BioMed Central

A novel prognostic score of recurrence for endometrial cancer patients with staging surgery BioMed Central

Published: Dec. 30, 2024, 4:33 a.m.
Read Full Article
A novel prognostic score of recurrence for endometrial cancer patients with staging surgery - bmcwomenshealth.biomedcentral.com

A novel prognostic score of recurrence for endometrial cancer patients with staging surgery bmcwomenshealth.biomedcentral.com

Published: Dec. 30, 2024, 4:33 a.m.
Read Full Article
Common condition linked with increased cancer and early death risks - MSN

Common condition linked with increased cancer and early death risks MSN

Published: Dec. 29, 2024, 2:30 a.m.
Read Full Article
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of pembrolizumab for locally advanced uterine cervical cancer, and durvalumab and olaparib for advanced or recurrent endometrial cancer in Japan - springermedicine.com

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of pembrolizumab for locally advanced uterine cervical cancer, and durvalumab and olaparib for advanced …

Published: Dec. 28, 2024, 12:47 p.m.
Read Full Article
A machine learning-based immune response signature to facilitate prognosis prediction in patients with endometrial cancer | Scientific Reports - Nature.com

A machine learning-based immune response signature to facilitate prognosis prediction in patients with endometrial cancer | Scientific Reports Nature.com

Published: Dec. 28, 2024, 2:37 a.m.
Read Full Article
A machine learning-based immune response signature to facilitate prognosis prediction in patients with endometrial cancer - Nature.com

A machine learning-based immune response signature to facilitate prognosis prediction in patients with endometrial cancer Nature.com

Published: Dec. 28, 2024, 2:37 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!